The biopharmaceutical market is on a trajectory of rapid growth, influenced by the increasing prevalence of chronic diseases, significant advancements in the medical sector, and robust investments from leading life sciences companies. In 2023, the biopharmaceutical market was valued at USD 438.79 billion. With a forecasted compound annual growth rate (CAGR) of 7.6% from 2024 to 2032, the market...